The Plight And Solution Of Basic Drug Supervision Under The Market Supervision System Trinity

In the new journey to "healthy China 2030",drug safety is not only related to the people's life and health and vital interests,but also to the reputation of the enterprise and the image of the country.Drug safety involves production,sale,use and so on.Any problems in one link will affect the health of the people.Because of the special properties of drugs,it should be treated differently from other products and cannot rely on the market completely,but the quality and safety should be ensured through strict drug regulation,this has brought considerable pressure and challenges to drug regulation Since entering the twenty-first Century,the reform of drug regulatory agencies has been continuous,the alarm of drug safety remains constant,but the occurrence of "toxic Capsules" and other events has greatly damaged the credibility of the government.In 2013,the party's the third Plenary Session of the 18 th CPC Central Committee,the first "reform of the market supervision system,the implementation of the unified market regulation" requirements,a period of time all over the country "two in one" "three in one" type of Market Supervision Bureau sprang out,integrated the original industry and Commerce Bureau,the food and Drug Administration Bureau,Quality Supervision Bureau functions,unified the power and responsibility of food and drug administration.The original intention of the "three in one" market supervision model undoubtedly embodies the foresight of the party and the state on food and drug regulation,but for the particularity and professionalism of the drug supervision at the grass-roots level,the drug regulation has been weakened because of the frequent institutional reform,the slow integration of the institutions and the differences in the mode of supervision.As the last mile of drug quality and safety,every county's urban Bureau and even the grass-roots station bear the heavy responsibility of people's safe medication,the weakening of drug professional supervision will undoubtedly threaten the health and life of the masses.Therefore,strengthening the supervision of drug safety at the grass-roots level is urgent.This paper introduces the research background and research significance of Ruian Market Supervision Bureau in Wenzhou,Zhejiang province.On the basis of clarifying the background,purpose and research ideas of the problem,the research methods of literature analysis,comparative analysis,case analysis and qualitative and quantitative combination are used to clarify the research background,purpose and research ideas of the problem,firstly the status quo of drug supervision in Ruian is comprehensively reviewed from the aspects of institution establishment,division of powers,staffing and supervision objects,the analysis shows that the drug supervision in Ruian is in the disadvantaged position,the supervision of the pharmaceutical supervision is in a difficult position,the quantity and quality of the licensed pharmacists are double restricted,the rules of the prescription flow are still difficult to be hidden,and the supervision responsibility is unequal under the unequal power and responsibility.A profound analysis of the causes of these difficulties,including institutional reform,sector integration,differences in regulatory approaches,and the fact that licensed pharmacists are not included in legal supervision,etc.On this basis,through the comparison and analysis of the typical experience of the basic drug supervision under the market supervision system of Shenzhen model,Tianjin model and Zhejiang model in the urban area of the mainland of China,we can draw lessons from the experience of drug supervision in the developed countries,Combined with the reality of the city,the "three in one" market supervision system is put forward: go deep into grass-roots research,and rationally and scientifically plan the standards for drug evaluation at the grass-roots level;building a unified and authoritative drug regulatory system from top to bottom,scientifically dividing the power of affairs,maintaining the professionalism of the regulatory and regulatory models,building a professional team,and ensuring the allocation of regulatory resources;to crack down on policy risks,to restrict licensed pharmacists from legislation,regulation and institutional level,and to develop channels for prescription sources;promoting the "duty free" system of regulatory personnel.